Influence of the Time Interval until the Start of adjuvant Chemotherapy on Overall Survival in Patients with triple-negative Breast Cancer

被引：0
|
作者：
Hatzipanagiotou, M. E. [1 ]
Pigerl, M. C. [1 ]
Gerken, M. [2 ,3 ]
Raepple, S. [1 ]
Zeltner, V [1 ]
Ugocsai, P. [1 ]
Ortmann, O. [1 ]
Klinkhammer-Schalke, M. [2 ,3 ]
Seitz, S. [1 ]
机构：
[1] Lehrstuhl Univ Regensburg, Caritas Krankenhaus St Josef, Klin Frauenheilkunde & Geburtshilfe, Regensburg, Germany
[2] Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr, Regensburg, Germany
[3] Bavarian Hlth & Food Safety Author, Reg Ctr Regensburg, Bavarian Canc Registry, Regensburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 06期
关键词：
D O I：
10.1055/s-0043-1768845
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P49
引用
收藏
页码：739 / 740
页数：2
相关论文
共 50 条
  • [41] Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
    Woriax, Hannah E.
    Thomas, Samantha M.
    Plichta, Jennifer K.
    Rosenberger, Laura H.
    Botty van den Bruele, Astrid
    Chiba, Akiko
    Hwang, E. Shelley
    Dinome, Maggie L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (14) : 1635 - 1645
  • [42] Does Time to Adjuvant Chemotherapy Affect Outcomes in Patients with Triple Negative Breast Cancer?
    Pomponio, Maria
    Keele, Luke
    Tchou, Julia C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : E76 - E77
  • [43] Effect of incorporation of cisplatin to adjuvant chemotherapy for triple-negative breast cancer patients of unknown BRCA mutation status on survival.
    Hung, Chia-Yen
    Su, Ying-Wen
    Hsieh, Ruey Kuen
    Lam, Hung-Bun
    Chang, Yuan-Ching
    Yang, Po-Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Early Triple-Negative Breast Cancer
    Arora, Shalabh
    Kumar, Akash
    Batra, Atul
    JAMA ONCOLOGY, 2021, 7 (03) : 460 - 461
  • [45] Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
    Liao, Yuqian
    Liao, Yulu
    Li, Jun
    Li, Junyu
    Fan, Ying
    Xu, Binghe
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3801 - 3808
  • [46] CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer
    Liu, Ming
    Tsang, Julia Y. S.
    Lee, Michelle
    Ni, Yun-Bi
    Chan, Siu-Ki
    Cheung, Sai-Yin
    Hu, Jintao
    Hu, Hong
    Tse, Gary M. K.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (11) : 1007 - 1014
  • [47] Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response
    Fisher, Carla S.
    Ma, Cynthia X.
    Gillanders, William E.
    Aft, Rebecca L.
    Eberlein, Timothy J.
    Gao, Feng
    Margenthaler, Julie A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) : 253 - 258
  • [48] Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response
    Carla S. Fisher
    Cynthia X. Ma
    William E. Gillanders
    Rebecca L. Aft
    Timothy J. Eberlein
    Feng Gao
    Julie A. Margenthaler
    Annals of Surgical Oncology, 2012, 19 : 253 - 258
  • [49] The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
    Fu, Wen-Fen
    Chen, Qing-Xia
    Wang, Xiao-Xiao
    Zhang, Jie
    Song, Chuan-Gui
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer
    Kai Huang
    James Jakub
    Emmanuel Gabriel
    Alvaro Moreno-Aspitia
    Sarah McLaughlin
    Annals of Surgical Oncology, 2023, 30 : 7026 - 7035
12345